Lupin receives tentative approval from U.S. FDA for Obeticholic Acid Tablets

Lupin receives tentative approval from U.S. FDA for Obeticholic Acid Tablets

Obeticholic Acid Tablets had estimated annual sales of USD 255 million in the U.S. (IQVIA MAT December 2022).

FPJ Web DeskUpdated: Thursday, March 23, 2023, 04:49 PM IST
article-image
Lupin receives tentative approval from U.S. FDA for Obeticholic Acid Tablets | Image: Lupin (Representative)

Global pharma major Lupin Limited (Lupin) today announced that it has received tentative approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application (ANDA), Obeticholic Acid Tablets, 5 mg and 10 mg, to market a generic equivalent of Ocaliva® Tablets, 5 mg and 10 mg, of Intercept Pharmaceuticals, Inc.

Obeticholic Acid Tablets (RLD Ocaliva) had estimated annual sales of USD 255 million in the U.S. (IQVIA MAT December 2022).

Lupin shares

The shares of Lupin on Thursday closed at Rs 648.80, down by 1.53 per cent.

RECENT STORIES

Vastu Tips To Consider While Buying Home

Vastu Tips To Consider While Buying Home

RBI MPC Keeps Interest Rates Unchanged; Industry Stalwarts React

RBI MPC Keeps Interest Rates Unchanged; Industry Stalwarts React

Tip To Choose Elevator Service And Maintenance Company

Tip To Choose Elevator Service And Maintenance Company

FICCI Conference On Business-Friendly Cities Highlights The Success Of Smart Cities Mission

FICCI Conference On Business-Friendly Cities Highlights The Success Of Smart Cities Mission

'EVMs Should Be Eliminated': Tesla CEO Elon Musk Cautions Over AI & Human Hacking Of Voting Machines

'EVMs Should Be Eliminated': Tesla CEO Elon Musk Cautions Over AI & Human Hacking Of Voting Machines